Literature DB >> 14983086

The distinct heme coordination environments and heme-binding stabilities of His39Ser and His39Cys mutants of cytochrome b5.

Wen-Hu Wang1, Jun-Xia Lu, Ping Yao, Yi Xie, Zhong-Xian Huang.   

Abstract

A gene mutant library containing 16 designed mutated genes at His39 of cytochrome b(5) has been constructed by using gene random mutagenesis. Two variants of cytochrome b(5), His39Ser and His39Cys mutant proteins, have been obtained. Protein characterizations and reactions were performed showing that these two mutants have distinct heme coordination environments: ferric His39Ser mutant is a high-spin species whose heme is coordinated by proximal His63 and likely a water molecule in the distal pocket, while ferrous His39Ser mutant has a low-spin heme coordinated by His63 and Ser39; on the other hand, the ferric His39Cys mutant is a low-spin species with His63 and Cys39 acting as two axial ligands of the heme, the ferrous His39Cys mutant is at high-spin state with the only heme ligand of His63. These two mutants were also found to have quite lower heme-binding stabilities. The order of stabilities of ferric proteins is: wild-type cytochrome b(5) >> His39Cys > His39Ser.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14983086     DOI: 10.1093/protein/gzg134

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  14 in total

1.  Heme ligand identification and redox properties of the cytochrome c synthetase, CcmF.

Authors:  Brian San Francisco; Eric C Bretsnyder; Kenton R Rodgers; Robert G Kranz
Journal:  Biochemistry       Date:  2011-11-21       Impact factor: 3.162

2.  Forced unfolding of apocytochrome b5 by steered molecular dynamics simulation.

Authors:  Ying-Wu Lin; Zhong-Hua Wang; Feng-Yun Ni; Zhong-Xian Huang
Journal:  Protein J       Date:  2008-04       Impact factor: 2.371

3.  A conserved haem redox and trafficking pathway for cofactor attachment.

Authors:  Cynthia L Richard-Fogal; Elaine R Frawley; Eric R Bonner; Huifen Zhu; Brian San Francisco; Robert G Kranz
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

4.  Molecular modeling and dynamics simulation of a histidine-tagged cytochrome b₅.

Authors:  Ying-Wu Lin; Tian-Lei Ying; Li-Fu Liao
Journal:  J Mol Model       Date:  2010-07-11       Impact factor: 1.810

5.  Structural stability and heme binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase domain.

Authors:  Jennifer L Meitzler; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2011-06-17       Impact factor: 4.013

6.  Interactions of uranyl ion with cytochrome b₅ and its His39Ser variant as revealed by molecular simulation in combination with experimental methods.

Authors:  Dun Wan; Li-Fu Liao; Min-Min Zhao; Min-Long Wu; Yi-Mou Wu; Ying-Wu Lin
Journal:  J Mol Model       Date:  2011-06-09       Impact factor: 1.810

Review 7.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

8.  Ligand accessibility to heme cytochrome b5 coordinating sphere and enzymatic activity enhancement upon tyrosine ionization.

Authors:  Alejandro K Samhan-Arias; Cristina M Cordas; Marta S Carepo; Luisa B Maia; Carlos Gutierrez-Merino; Isabel Moura; José J G Moura
Journal:  J Biol Inorg Chem       Date:  2019-03-05       Impact factor: 3.358

9.  Human mitochondrial holocytochrome c synthase's heme binding, maturation determinants, and complex formation with cytochrome c.

Authors:  Brian San Francisco; Eric C Bretsnyder; Robert G Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

10.  Replacement of the axial histidine heme ligand with cysteine in nitrophorin 1: spectroscopic and crystallographic characterization.

Authors:  Stefan W Vetter; Andrew C Terentis; Robert L Osborne; John H Dawson; David B Goodin
Journal:  J Biol Inorg Chem       Date:  2008-10-16       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.